BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 15138170)

  • 1. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease.
    Ledue TB; Collins MF; Young J; Schriefer ME
    Clin Vaccine Immunol; 2008 Dec; 15(12):1796-804. PubMed ID: 18945880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescent bead-based multiplex assay for the simultaneous detection of antibodies to B. burgdorferi outer surface proteins in canine serum.
    Wagner B; Freer H; Rollins A; Erb HN
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):190-8. PubMed ID: 21208663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune responses to borrelial VlsE IR6 peptide variants.
    Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
    Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans.
    Philipp MT; Bowers LC; Fawcett PT; Jacobs MB; Liang FT; Marques AR; Mitchell PD; Purcell JE; Ratterree MS; Straubinger RK
    J Infect Dis; 2001 Oct; 184(7):870-8. PubMed ID: 11550127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay.
    Liang FT; Jacobson RH; Straubinger RK; Grooters A; Philipp MT
    J Clin Microbiol; 2000 Nov; 38(11):4160-6. PubMed ID: 11060084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
    Eschner AK; Mugnai K
    Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE.
    Liang FT; Steere AC; Marques AR; Johnson BJ; Miller JN; Philipp MT
    J Clin Microbiol; 1999 Dec; 37(12):3990-6. PubMed ID: 10565920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.
    Grosenbaugh DA; Rissi DR; Krimer PM
    Vet Immunol Immunopathol; 2016 Nov; 180():29-33. PubMed ID: 27692092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.
    Straubinger RK; Dharma Rao T; Davidson E; Summers BA; Jacobson RH; Frey AB
    Vaccine; 2001 Oct; 20(1-2):181-93. PubMed ID: 11567763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi.
    Liang FT; Alvarez AL; Gu Y; Nowling JM; Ramamoorthy R; Philipp MT
    J Immunol; 1999 Nov; 163(10):5566-73. PubMed ID: 10553085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis.
    Fawcett PT; Rose CD; Budd SM; Gibney KM
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi.
    Levy S; O'Connor TP; Hanscom JL; Shields P
    Vet Ther; 2002; 3(3):308-15. PubMed ID: 12447839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.
    LaFleur RL; Dant JC; Wasmoen TL; Callister SM; Jobe DA; Lovrich SD; Warner TF; Abdelmagid O; Schell RF
    Clin Vaccine Immunol; 2009 Feb; 16(2):253-9. PubMed ID: 19052162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL.
    Liang FT; Aberer E; Cinco M; Gern L; Hu CM; Lobet YN; Ruscio M; Voet PE; Weynants VE; Philipp MT
    J Infect Dis; 2000 Nov; 182(5):1455-62. PubMed ID: 11023468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.